Sime to invest RM97.7mil in US biotech company Verdezyne


President Barack Obama, standing right, and Malaysian Prime Minister Najib, standing left, applaud as Bill Radany, president & CEO of Verdezyne, right, and Tan Sri Dato' Seri Mohd Bakke Salleh, President & Group Chief Executive of Sime Darby Berhad, left, participate in the signing of major commercial agreements with American businesses at the Ritz-Carlton in Kuala Lumpur,

PETALING JAYA: Sime Darby Bhd is acquiring a substantial stake in United States-based industrial biotechnology company Verdezyne Inc to pursue strategic growth areas for its plantation business.

Sime Darby president and group chief executive officer Tan Sri Mohd Bakke Salleh said in a statement that “Sime Darby is taking strategically measured steps to build and nurture a sustainable portfolio of palm-related industrial biotechnology companies.

The Star Festive Promo: Get 35% OFF Digital Access

Monthly Plan

RM 13.90/month

Best Value

Annual Plan

RM 12.33/month

RM 8.02/month

Billed as RM 96.20 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Business , Sime Darby , Verdezyne , Barack Obama , Najib

Next In Business News

Trading ideas: Steel Hawk, Critical, GDB, Hextar Industries, Infraharta, MFM, MGB, Oriental, UEM Sunrise, Maxis, SKP
Malaysia clinches RM1.8bil sales at Gulfood 2026
Steel Hawk unit secures PETRONAS deal
One Credit debuts smart fintech system
Dividend yield catalyst for CelcomDigi re-rating
HIB acquires 51% stake in Woodpeckers
Dialog enters recovery year driven by midstream recurring income
OGX launches IPO ahead of ACE Market listing
Critical Holdings wins RM35mil design contract
Rousing outlook for Heineken in FY26

Others Also Read